PVRI 2027 Abstracts

Submit your abstract under one of the five themes for the opportunity to present your work at PVRI 2027 Bangkok, be considered for an award, and contribute to the scientific programme. 

1. Basic &Translational Science
2. Clinical Science
3. International & Global Health
4. Mind the Gap: Cases that Highlight Gaps in Evidence
5. Next-Generation Diagnostics, AI & Therapeutics

Submit your abstract

Best Early-Career Abstract Awards

Seven awards of £2,000 each (increased from three £500 grants) will be awarded to early career lead authors of the best submitted abstracts submitted to PVRI 2027. As well as the £2,000 Rupert Swift Award, and the Butrous Foundation Young Investigator Award. 

During abstract submission, you’ll be able to indicate whether you would like your abstract to be considered for eligible awards. All submitted abstracts may be considered for an oral presentation in the main Congress programme. 
 

Key Dates

Abstract Guidelines

Please read the full abstract guidelines, terms and conditions below before submitting. Key points:

• NB: You must have an active PVRI membership to submit an abstract. To ensure our membership is accessible to the widest possible global community, our fees are discounted for early-career professionals and those in LMICs. Not a member? Become a member today.
• Abstracts must be submitted in English through the PVRI 2027 abstract portal
• Abstract titles can be up to 50 words
• Abstracts must be no more than 300 words
• Figures and tables are not allowed
• All authors and affiliations must be added in full, in English
• The abstract title, authors, and affiliations are not included in the word count
• There is no fee to submit, but you must have an active PVRI membership
• You’ll be asked whether you want your abstract to be considered for an award
• The text version of accepted abstracts will be published, with your permission, in Pulmonary Circulation
• All correspondence will be sent to the submitting author
• The organisers may amend your category during the review process
   

Late-breaking abstracts

Late-breaking abstracts should be expected to substantially advance the diagnosis, management, or understanding of PH. They should report highly impactful, novel findings that became available after the main abstract submission deadline. Priority will be given to presentations of:

• major clinical trials
• landmark registry analyses
• transformative translational discoveries
• emerging technologies with immediate clinical relevance

Abstract Guidelines